Figure 3. Patient disposition. ^aReceived ≥1 dose belimumab; ^bpatients included in the ITT population for whom ≥1 post belimumab treatment PK sample was analyzed. AE = adverse event; ITT = intent-to-treat; PK = pharmacokinetic.